France · Delayed Price · Currency is EUR Biophytis Statistics
Total Valuation
Biophytis has a market cap or net worth of EUR 1.48 million. The enterprise value is 7.95 million.
| Market Cap | 1.48M |
| Enterprise Value | 7.95M |
Important Dates
The next estimated earnings date is Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biophytis has 23.40 million shares outstanding. The number of shares has increased by 384.68% in one year.
| Current Share Class | 23.40M |
| Shares Outstanding | 23.40M |
| Shares Change (YoY) | +384.68% |
| Shares Change (QoQ) | +179.95% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 8.14% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.99 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.25 |
Financial Position
The company has a current ratio of 0.35
| Current Ratio | 0.35 |
| Quick Ratio | 0.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.21 |
| Interest Coverage | -11.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -66.56% |
| Return on Invested Capital (ROIC) | -319.92% |
| Return on Capital Employed (ROCE) | 187.32% |
| Weighted Average Cost of Capital (WACC) | 7.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -422,632 |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.38% in the last 52 weeks. The beta is 0.18, so Biophytis's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -79.38% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 46.43 |
| Average Volume (20 Days) | 1,533,872 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.17M |
| Pretax Income | -8.03M |
| Net Income | -8.03M |
| EBITDA | -7.87M |
| EBIT | -8.17M |
| Earnings Per Share (EPS) | -0.61 |
Balance Sheet
The company has 1.21 million in cash and 7.72 million in debt, with a net cash position of -6.51 million or -0.28 per share.
| Cash & Cash Equivalents | 1.21M |
| Total Debt | 7.72M |
| Net Cash | -6.51M |
| Net Cash Per Share | -0.28 |
| Equity (Book Value) | -7.82M |
| Book Value Per Share | -0.33 |
| Working Capital | -7.14M |
Cash Flow
In the last 12 months, operating cash flow was -6.38 million and capital expenditures 9,000, giving a free cash flow of -6.38 million.
| Operating Cash Flow | -6.38M |
| Capital Expenditures | 9,000 |
| Free Cash Flow | -6.38M |
| FCF Per Share | -0.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biophytis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -384.68% |
| Shareholder Yield | -384.68% |
| Earnings Yield | -543.77% |
| FCF Yield | -431.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.0025.
| Last Split Date | May 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |